References
- Raju TNK The Nobel chronicles. Lancet. 2000;355:1022. 9208.
- Ioannidis JPA Why most published research findings are false. PLoS Med. 2005;2. 10.1371/journal.pmed.0020124.
- Prinz F, Schlange T, Asadullah K Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011;10:712–713.
- Begley CG, Ellis LM Drug development: raise standards for preclinical cancer research. Nature. 2012;483:531–533.
- Baker M Biotech giant posts negative results. Nature. 2016;530:141.
- Lehrer J The truth wears off: is there something wrong with the scientific method? The New Yorker. 2010. [Cited 2020 Nov 7]. Available from: http://www.newyorker.com/reporting/2010/12/13/101213fa_fact_lehrer
- Briefing. Trouble at the lab. The Economist. 2013. [Cited 2020 Nov 7]. Available from: https://www-economist-com.ezproxy.neu.edu/briefing/2013/10/18/trouble-at-the-lab.
- Ackermann AM, Moss NG, Kaestner KH GABA and artesunate do not induce pancreatic α-to-β cell transdifferentiation in vivo. Cell Metab. 2018;28:787–792.
- Xu F-X, Zhou L, Wang X-T, et al. Magneto is ineffective in controlling electrical properties of cerebellar Purkinje cells. Nature Neurosci. 2020;23:1041–1043.
- Baker M 1,500 scientists lift the lid on reproducibility Nature. 2016;533:452–454. 7604.
- Freedman LP, Cockburn IM, Simcoe TS The economics of reproducibility in preclinical research. PLoS Biol. 2015;13:e1002165. [Cited 2020 Nov 7]. Available from: https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002165.
- Hill RG, Richards D (eds.). Drug Discovery and Development: technology in Transition, 3rd Edition . London: Churchill Livingstone/ Elsevier, 2020.
- Wills TJ, Lipkus AH Structural approach to assessing the innovativeness of new drugs finds accelerating rate of innovation. 2020. ACS Med Chem Lett. [Cited 2020 Nov 7. Available from: https://dx.doi.org/10.1021/acsmedchemlett.0c00319.
- Scannell JW, Blanckley A, Boldon H, et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11:191–200.
- Deloitte. Measuring the return from pharmaceutical innovation 2019. [cited 2020 Nov 7]. Available from: https://www2.deloitte.com/uk/en/pages/life-sciences-andhealthcare/articles/measuring-return-from-pharmaceutical-innovation.html.
- McCarthy J Big pharma sinks to the bottom of U.S. industry rankings. 2019. [cited 2020 Nov 7]. Available from: https://news.gallup.com/poll/266060/big-pharma-sinks-bottom-industry-rankings.aspx?
- Flier JS Academia and industry: allocating credit for discovery and development of new therapies. J Clin Invest. 2019;129:2172–2174.
- Bickle M The academic pill: how academia contributes to curing diseases. SLAS Discovery. 2019;24:203–212.
- Janero DR Positioning for success in university-industry drug-discovery collaborations: initiatives toward effective trans-constituency team science. Int J Drug Dev & Res. 2015;7:4 [cited 2020 Nov 7]. Availablefrom: https://www.ijddr.in/drugdevelopment/positioning-for-success-in-universityindustry-drugdiscoverycollaborations-initiativestowards-effective-transconstituency-teamscie.php?aid=7958
- Bryans JS, Kettleborough KA, Solari R Are academic drug discovery efforts receiving more recognition with declining industry efficiency? Expert Opin Drug Discov. 2019;14:605–607.
- National Science Foundation. Survey of graduate students and postdoctorates in science and engineering. 2018. [Cited 2020 Nov 7]. Available from: https://www.nsf.gov/statistics/srvygradpostdoc/.
- Pharmaceutical Research and Manufacturers of America (PhRMA). Enhancing today’sSTEM workforce to ensure tomorrow’s new medicines. 2018. [Cited 2020 Nov 7]. Available from: http://phrma-docs.phrma.org/files/dmfile/TEConomy-PhRMA-STEM-Report-Final.pdf.
- Ioannidis JPA Why science is not necessarily self-correcting. Perspect Psychol Sci. 2012;7:645–654.
- Lithgow GJ, Driscoll M, Phillips P A long journey to reproducible results. Nature. 2017;548:387–388.
- Eisner DA Reproducibility of science: fraud, impact factors and carelessness. J Mol Cell Cardiol. 2018;114:364–368.
- Begley CG, Ioannidis JPA Reproducibility in science: improving the standard for basic and preclinical research. Circ Res. 2015;116:116–126.
- Hirsch C, Schildknecht S In vitro research reproducibility: keeping up high standards. Front Pharmacol. 2019;10:1484. Published online2019 Dec 10.
- Kannt A, Wieland T Managing risks in drug discovery: reproducibility of published findings. Naunyn-Schmiedberg’s Arch Pharmacol. 2016;389:353–360.
- Janero DR. Developing doctoral scientists for drug discovery: pluridimensional education required. Expert Opin Drug Disc. 2013;8:105-113.
- Stupple A, Singerman D, Celi LA The reproducibility crisis in the age of digital medicine. Npj Digital Med. Published online 29 Jan 2019. DOI: 10.1038/s41746-019-0079-z.
- Harvard Medical School. Office for academic and research integrity. [ cited 2020 Nov 7]. Available from: https://ari.hms.harvard.edu/.
- National Institutes of Health. Final NIH Policy for Data Management and Sharing. 2020. [Cited 2020 Nov 7]. Available from: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-013.html.
- Hrynaszkiewicz I Publishers’ responsibilities in promoting data quality and reproducibility. Handb Exp Pharmacol. 2020;257:319–348.
- Fanga FC, Steenc RG, Casadevalld A Misconduct accounts for the majority of retracted scientific publications. Proc Natl Acad Sci USA. 2012;109:17028–17033.
- Bhatt B A multi-perspective analysis of retractions in life sciences. bioRxiv. Published online 1 May 2020. [Cited 2020 Nov 7]. DOI: 10.1101/2020.04.29.063016.
- Müller MJ, Landsberg B, Ried J Fraud in science: a plea for a new culture in research.Eur J Clin Nutr. 2014;68:411–415.
- Maher B, Anfres MS Under pressure. Nature. 2016;538:444–445.
- Matthews KR, Calhoun KM, Lo N, et al. The aging of biomedical research in the United States. PLoS One. 2011;6:e29738.
- Miller AN, Bedeian AG Publish or perish: academic life as we live it. Acad Mgmt. Published online 2017 Nov 30. DOI: 10.1108/13620431111167751.
- Conte ML, Liu J, Schnell S, et al. Globalization and changing trends of biomedical research output. JCI Insight. 2017;2:e95206.Published online 2017 Jun 15.
- Sekar K NATIONAL institutes of health (NIH) funding: FY1995-FY2021. congressional research service. 2020. [Cited 2020 Nov 7]. Available from: https://www.everycrsreport.com/files/20200512_R43341_19653b6353c08fd6c4c38d357a2161ae71ed0822.pdf.
- Feldon DF, Liston K, Jeong S, et al. Postdocs’ lab engagement predicts trajectories of PhD students’ skill development. Proc Natl Acad Sci USA. 2019;116:20910–20916.
- Flaherty C Postdocs as mentors. Inside Higher Ed. 2019. [Cited 2020 Nov 7]. Available from: https://www.insidehighered.com/news/2019/10/11/study-says-when-it-comes-everyday-mentoring-and-training-sciences-postdocs-are-new
- LaFollette MC The evolution of the “scientific misconduct” issue: an historical overview. Proc Soc Exp Biol Med. 2000;224:211–215.
- Fanelli D How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One 2009;4:e5738.
- Steneck NH Fostering integrity in research: definitions, current knowledge, and future directions. Sci Eng Ethics. 2006;12:53–74.
- Casci T, Adams E Research culture: setting the right tone. eLife. Published online2020 Feb 10. DOI: 10.7554/eLife.55543.
- Na B, Pinxten W Rethinking success, integrity, and culture in research (part 2) A multi-actor qualitative study on problems of science. bioRxiv. Published online 17 Feb 2020. DOI: 10.1101/2020.02.12.945899.
- Munafό MR, Chambers CD, Collins AM, et al. Research culture and reproducibility. Trends Cognit Sci 2020;24:91–93.
- Fang FC, Casadevall A Reforming science: structural reforms. Infect Immun 2012;80:897–901.
- De Caluwé L, Vermaak H Change paradigms: an overview. Organ Dev J 2004;22:9–18.
- Diamond RM Why colleges are so hard to change. Published online 2006 Sept 8. https://www.insidehighered.com/views/2006/09/08/why-colleges-are-so-hard-change162 .
- US National Library of Medicine. Number of authors per MEDLINE/PubMed citation. Published online 15 May 2020. nlm.nih.gov/bsd/authors1.html.
- Bloom Q, Curran M, Brint S Interdisciplinary cluster hiring initiatives in U.S. research universities: more straw than bricks? J Higher Educ. 2020;91:755–780.
- Cleary EG, Beierlein JM, Khanujla NS, et al. Contributions of NIH funding to new drug approvals 2010-2016. Proc Natl Acad Sci USA 2018;115:2329–2334.
- The Royal Society. History of the Royal Society. [ cited 2020 Nov 7] Available from:https://royalsociety.org/about-us/history/.
- Janero DR. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca. Expert Opin Drug Disc. 2012;7:449–456
- Katsila T, Matsoukas M-T. How far have we come with contextual data integration in drug discovery? Expert Opin Drug Discov. 2018;9:791–794
- Schaduangrat N, Lampa S, Siemon S, et al. Towards reproducible computational drug discovery. J Cheminform. Published online 28 Jan 2020. https://doi.org/10.1186/s13321-020-0408-x
- Kanakan A, Mishra N, Vasudevan JS, et al. Threading the pieces together: integrative perspective in SARS-CoV-2. Pathogens. 2020;9:912. Published online 4 November 2020. https://doi.org/10.3390/pathogens9110912.
- Palayew A, Norgaard O, Safreed-Harmon K, et al. Pandemic publishing poses a new COVID-19 challenge. Nat Hum Behav. 2020;4:666–669.